(Q54016634)

23 May 2018

title

CD36, insulin resistance, and coronary heart disease. (English)

1 reference

23 May 2018

1 reference

T J Aitman

1

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

23 May 2018

published in

The Lancet

1 reference

23 May 2018

volume

357

1 reference

23 May 2018

issue

9257

1 reference

23 May 2018

page(s)

651-652

1 reference

23 May 2018

Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Cellular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Apoptosis. Phagocytic docking without shocking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

Malaria susceptibility and CD36 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904149-0

7 January 2021

10.1016/S0140-6736(00)04149-0

Identifiers

DOI

1 reference

23 May 2018

1 reference

23 May 2018